http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114053413-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65edc0ba3929354a87b987efefb82bfb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b69920806b55a680bcd8f71a2c8a4dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc8ef2cf85960033f4420f6b9530a434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a92556ccde73596c0edfd8cfad8f2b35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dccb91de8b027a99bc9363166939cb99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798bd566a8c458f7fc40942eb697bdbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa29a9ee206af01a9bd68920bbcaf0b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12adc57e37236b113bbc2c612a7733e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a0e0bc9989fe71b68f6c19113eb3ae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e390f63c0ffa5851c9f838adc6a59373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6347d5c4d830a287716a3f553f7b18fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589a7ada3e278eaaf9bd56bee851a355
publicationDate 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114053413-A
titleOfInvention Application of a COL4A4 gene as a therapeutic target for acute ischemic stroke
abstract The invention provides an application of COL4A4 gene as a therapeutic target of acute ischemic stroke, in particular to the preparation of molecular targeted drugs for preventing and/or treating acute ischemic stroke, and the preparation of acute ischemic stroke Neuroprotective agent. The COL4A4 of the present invention is highly conserved in human-derived or mouse-derived species. Through knockdown or overexpression experiments of COL4A4, it is confirmed that COL4A4 can be used as a target for the treatment of acute ischemic stroke, and can be used to prepare molecular targeted drugs to reduce deficiency Hypoxic neuronal apoptosis. The invention provides a new target for developing neuroprotective drugs for acute ischemic stroke.
priorityDate 2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689061
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25402
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554270
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43514
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12829
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID461669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4021
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID301562
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42008
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1286
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403567

Total number of triples: 42.